WallStreetZenWallStreetZen

NASDAQ: ABOS
Acumen Pharmaceuticals Inc Stock

$4.08+0.20 (+5.15%)
Updated Mar 22, 2023
ABOS Price
$4.08
Fair Value Price
N/A
Market Cap
$166.98M
52 Week Low
$3.02
52 Week High
$10.97
P/E
3.29x
P/B
0.85x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$38.34M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.03
Operating Cash Flow
-$28M
Beta
1.25
Next Earnings
Mar 27, 2023
Ex-Dividend
N/A
Next Dividend
N/A

ABOS Overview

Acumen Pharmaceuticals Inc. develops therapies for the treatment of Alzheimer's disease. Acumen's approach targets AbOs, a toxic and pathogenic form of Ab relative to Ab monomers and amyloid plaques. The company's lead immunotherapy drug candidate ACU193, is a humanized monoclonal antibody that is in Phase I clinical-stage trials. Acumen Pharmaceuticals was incorporated in 1996 and is headquartered in Charlottesville, VA.

Zen Score

Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ABOS scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ABOS is good value based on its earnings relative to its share price (3.29x), compared to the US market average (22.44x)
P/E vs Market Valuation
ABOS is good value based on its earnings relative to its share price (3.29x), compared to the US Biotechnology industry average (16.9x)
P/E vs Industry Valuation
ABOS is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
There are 30 more ABOS due diligence checks available for Premium users.

Be the first to know about important ABOS news, forecast changes, insider trades & much more!

ABOS News

Valuation

ABOS fair value

Fair Value of ABOS stock based on Discounted Cash Flow (DCF)
Price
$4.08
Fair Value
$9.41
Undervalued by
56.64%

ABOS price to earnings (PE)

For valuing profitable companies with steady earnings
Company
3.29x
Industry
16.9x
Market
22.44x
ABOS is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
ABOS is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

ABOS price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.85x
Industry
4.76x
ABOS is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ABOS's financial health

Profit margin

Revenue
$0.0
Net Income
-$10.7M
Profit Margin
0%
ABOS's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$203.3M
Liabilities
$6.6M
Debt to equity
0.03
ABOS's short-term assets ($202.56M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ABOS's short-term assets ($202.56M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ABOS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$9.2M
Investing
$55.9M
Financing
-$263.0k
ABOS's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ABOS vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
ABOS$166.98M+5.15%3.29x0.85x
MACK$167.21M+1.47%-106.64x8.69x
PDSB$166.49M-7.15%-5.78x3.54x
RLYB$167.53M-10.57%-2.11x0.99x
THRD$166.23M-1.68%N/A0.56x

Acumen Pharmaceuticals Stock FAQ

What is Acumen Pharmaceuticals's quote symbol?

NASDAQ: ABOS) Acumen Pharmaceuticals trades on the NASDAQ under the ticker symbol ABOS. Acumen Pharmaceuticals stock quotes can also be displayed as NASDAQ: ABOS.

If you're new to stock investing, here's how to buy Acumen Pharmaceuticals stock.

What is the 52 week high and low for Acumen Pharmaceuticals (NASDAQ: ABOS)?

(NASDAQ: ABOS) Acumen Pharmaceuticals's 52-week high was $10.97, and its 52-week low was $3.02. It is currently -62.81% from its 52-week high and 35.1% from its 52-week low.

How much is Acumen Pharmaceuticals stock worth today?

(NASDAQ: ABOS) Acumen Pharmaceuticals currently has 40,925,284 outstanding shares. With Acumen Pharmaceuticals stock trading at $4.08 per share, the total value of Acumen Pharmaceuticals stock (market capitalization) is $166.98M.

Acumen Pharmaceuticals stock was originally listed at a price of $20.10 in Jul 1, 2021. If you had invested in Acumen Pharmaceuticals stock at $20.10, your return over the last 1 years would have been -79.7%, for an annualized return of -79.7% (not including any dividends or dividend reinvestments).

How much is Acumen Pharmaceuticals's stock price per share?

(NASDAQ: ABOS) Acumen Pharmaceuticals stock price per share is $4.08 today (as of Mar 22, 2023).

What is Acumen Pharmaceuticals's Market Cap?

(NASDAQ: ABOS) Acumen Pharmaceuticals's market cap is $166.98M, as of Mar 24, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Acumen Pharmaceuticals's market cap is calculated by multiplying ABOS's current stock price of $4.08 by ABOS's total outstanding shares of 40,925,284.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.